239 related articles for article (PubMed ID: 7593409)
1. Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors.
Hosokawa Y; Pollak MR; Brown EM; Arnold A
J Clin Endocrinol Metab; 1995 Nov; 80(11):3107-10. PubMed ID: 7593409
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
3. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.
Kifor O; Moore FD; Delaney M; Garber J; Hendy GN; Butters R; Gao P; Cantor TL; Kifor I; Brown EM; Wysolmerski J
J Clin Endocrinol Metab; 2003 Jan; 88(1):60-72. PubMed ID: 12519831
[TBL] [Abstract][Full Text] [Related]
4. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.
Cetani F; Pinchera A; Pardi E; Cianferotti L; Vignali E; Picone A; Miccoli P; Viacava P; Marcocci C
J Bone Miner Res; 1999 Jun; 14(6):878-82. PubMed ID: 10352095
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of primary hyperparathyroidism.
Brown EM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
Bai M; Pearce SH; Kifor O; Trivedi S; Stauffer UG; Thakker RV; Brown EM; Steinmann B
J Clin Invest; 1997 Jan; 99(1):88-96. PubMed ID: 9011580
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
9. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
10. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
Watanabe S; Fukumoto S
Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
[TBL] [Abstract][Full Text] [Related]
11. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of hyperparathyroid disease.
Tominaga Y; Takagi H
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):336-41. PubMed ID: 8823531
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
14. Activating mutations of the Ca2+-sensing receptor.
Mancilla EE; De Luca F; Baron J
Mol Genet Metab; 1998 Jul; 64(3):198-204. PubMed ID: 9719629
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the PTH 3'-untranslated region in parathyroid disorders.
Costa-Guda J; Lauter K; Naveh-Many T; Silver J; Arnold A
Clin Endocrinol (Oxf); 2006 Dec; 65(6):806-9. PubMed ID: 17121534
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
Samander EH; Arnold A
J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
[TBL] [Abstract][Full Text] [Related]
17. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
18. Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene.
Yamauchi M; Sugimoto T; Yamaguchi T; Yano S; Wang J; Bai M; Brown EM; Chihara K
J Bone Miner Res; 2002 Dec; 17(12):2174-82. PubMed ID: 12469911
[TBL] [Abstract][Full Text] [Related]
19. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
[TBL] [Abstract][Full Text] [Related]
20. Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism.
Marx SJ
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S19-24; discussion S31-2. PubMed ID: 1684885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
